Literature DB >> 24356567

miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc.

Feng Wang1, Jin Xia, Nengchao Wang, Hong Zong.   

Abstract

BACKGROUND: Accumulating evidence has shown that microRNAs (miRNAs) are aberrantly expressed in human esophageal cancer and crucial to tumorigenesis. Herein, we identified the role of miR-145 in esophageal squamous cell carcinoma (ESCC) development in vitro and in vivo.
MATERIAL AND METHODS: miR-145 expression was investigated in 40 ESCC samples as well as 5 ESCC cell lines by real-time polymerase chain reaction. Crystal violet and transwell assays were conducted to explore the effects of miR-145 on the proliferation and invasion of human ESCC cell lines, respectively. The impact of overexpression of miR-145 on putative target c-Myc was subsequently confirmed via Western blot.
RESULTS: miR-145 expression was frequently downregulated in ESCC specimens and cell lines compared with adjacent normal tissues (p < 0.05). Overexpression of miR-145 suppressed (p < 0.05) ESCC cell proliferation and invasion, as well as the growth of xenograft tumors in mice. Overexpression of miR-145 significantly decreased (p < 0.05) the protein level of c-Myc which has previously been identified as a direct target of miR-145.
CONCLUSION: Our results demonstrate that overexpression of miR-145 inhibits tumor growth in part by targeting c-Myc. Our findings revealed that miR-145 may act as a tumor suppressor in ESCC, and its dysregulation may be involved in the initiation and development of human ESCC.
© 2013 S. Karger GmbH, Freiburg.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24356567     DOI: 10.1159/000356978

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  27 in total

1.  The effect of recombinant lentiviral vector encoding miR-145 on human esophageal cancer cells.

Authors:  Tian-Yun Wang; Qing-Qing Zhang; Xi Zhang; Qiu-Li Sun; Chun-Peng Zhao; Xiao-Yin Wang
Journal:  Tumour Biol       Date:  2015-07-09

Review 2.  Oxidative stress response and Nrf2 signaling in aging.

Authors:  Hongqiao Zhang; Kelvin J A Davies; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2015-06-09       Impact factor: 7.376

3.  MicroRNA-based screens for synthetic lethal interactions with c-Myc.

Authors:  Youjun Li; Yahui Zhu; Edward V Prochownik
Journal:  RNA Dis       Date:  2016-05-30

4.  MiR-27a-3p promotes esophageal cancer cell proliferation via F-box and WD repeat domain-containing 7 (FBXW7) suppression.

Authors:  Xue-Zhi Wu; Kui-Peng Wang; Hong-Jie Song; Jian-Hua Xia; Yan Jiang; Yong-Lian Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  MicroRNA-145 Modulates N6-Methyladenosine Levels by Targeting the 3'-Untranslated mRNA Region of the N6-Methyladenosine Binding YTH Domain Family 2 Protein.

Authors:  Zhe Yang; Jiong Li; Guoxing Feng; Shan Gao; Yuan Wang; Shuqin Zhang; Yunxia Liu; Lihong Ye; Yueguo Li; Xiaodong Zhang
Journal:  J Biol Chem       Date:  2017-01-19       Impact factor: 5.157

Review 6.  MicroRNAs and Corresponding Targets in Esophageal Cancer as Shown In Vitro and In Vivo in Preclinical Models.

Authors:  Ulrich H Weidle; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2022 Mar-Apr       Impact factor: 4.069

7.  MiR-145 inhibits osteosarcoma cells proliferation and invasion by targeting ROCK1.

Authors:  Enqi Li; Jinli Zhang; Tianxiang Yuan; Baotong Ma
Journal:  Tumour Biol       Date:  2014-05-07

8.  Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway.

Authors:  Fang Li; Liyuan Zhang; Wei Li; Jieqiong Deng; Jian Zheng; Mingxing An; Jiachun Lu; Yifeng Zhou
Journal:  Oncotarget       Date:  2015-03-20

Review 9.  Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis.

Authors:  Ani V Das; Radhakrishna M Pillai
Journal:  Cancer Cell Int       Date:  2015-09-29       Impact factor: 5.722

10.  Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma.

Authors:  Xiaoyan He; Zhimei Zhang; Ming Li; Shuo Li; Lihua Ren; Hong Zhu; Bin Xiao; Ruihua Shi
Journal:  BMC Cancer       Date:  2015-08-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.